MedPlus Subsidiary Receives 5-Day Drug License Suspension

MedPlus subsidiary Optival Health Solutions received a 5-day drug license suspension for a store in Karnataka.
The suspension order was issued by Karnataka drug authorities under Drugs and Cosmetics Act, 1940 rules.
The company estimates potential revenue loss of ₹5.39 lakhs from the store suspension period.
This regulatory disclosure complies with SEBI Listing Obligations and Disclosure Requirements regulations.